MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy

被引：18

作者：

Chiti, Enrica ^{[1
]}

Paolo, Marco ^{[2
]}

Turillazzi, Emanuela ^{[2
]}

Rocchi, Anna ^{[2
]}

机构：

[1] Scuola Super Sant Anna, Inst Life Sci, I-56124 Pisa, Italy

[2] Univ Pisa, Inst Legal Med, Dept Surg Pathol, Mol & Crit Area, Via Roma 55, I-56126 Pisa, Italy

来源：

DIAGNOSTICS | 2021年 / 11卷 / 09期

关键词：

microRNAs; biomarkers; inherited cardiomyopathies; dilated cardiomyopathy; arrhythmogenic cardiomyopathy; hypertrophic cardiomyopathy; RIGHT-VENTRICULAR CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; TASK-FORCE; CIRCULATING MICRORNAS; EUROPEAN-SOCIETY; DOWN-REGULATION; DIAGNOSIS; EXPRESSION; HEART;

D O I：

10.3390/diagnostics11091720

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

MicroRNAs (miRNAs) are a class of non-coding RNAs of about 20 nucleotides in length, involved in the regulation of many biochemical pathways in the human body. The level of miRNAs in tissues and circulation can be deregulated because of altered pathophysiological mechanisms; thus, they can be employed as biomarkers for different pathological conditions, such as cardiac diseases. This review summarizes published findings of these molecular biomarkers in the three most common structural cardiomyopathies: human dilated, arrhythmogenic and hypertrophic cardiomyopathy.

引用

页数：18

共 120 条

[1] Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy [J].

Aquaro, Giovanni Donato ;

Guidi, Benedetta ;

Biondi, Federico ;

Chiti, Enrica ;

Santurro, Alessandro ;

Scopetti, Matteo ;

Turillazzi, Emanuela ;

Di Paolo, Marco .

DIAGNOSTICS, 2020, 10 (11)

[2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].

Bartel, David P. .

CELL, 2007, 131 (04) :11-29

[3] Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy [J].

Belmonte, Thalia ;

Mangas, Alipio ;

Calderon-Dominguez, Maria ;

Quezada-Feijoo, Maribel ;

Ramos, Monica ;

Campuzano, Oscar ;

Gomez, Silvia ;

Luisa Pena, Maria ;

Cubillos-Arango, Andres M. ;

Dominguez, Fernando ;

Llorente-Cortes, Vicenta ;

De Gonzalo-Calvo, David ;

Toro, Rocio .

TRANSLATIONAL RESEARCH, 2020, 218 :1-15

[4] Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both? [J].

Bennett, Richard G. ;

Haqqani, Haris M. ;

Berruezo, Antonio ;

Della Bella, Paolo ;

Marchlinski, Francis E. ;

Hsu, Chi-Jen ;

Kumar, Saurabh .

HEART LUNG AND CIRCULATION, 2019, 28 (01) :164-177

[5] Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy [J].

Bernardo, Bianca C. ;

Nguyen, Sally S. ;

Winbanks, Catherine E. ;

Gao, Xiao-Ming ;

Boey, Esther J. H. ;

Tham, Yow Keat ;

Kiriazis, Helen ;

Ooi, Jenny Y. Y. ;

Porrello, Enzo R. ;

Igoor, Sindhu ;

Thomas, Colleen J. ;

Gregorevic, Paul ;

Lin, Ruby C. Y. ;

Du, Xiao-Jun ;

McMullen, Julie R. .

FASEB JOURNAL, 2014, 28 (12) :5097-5110

[6] Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy [J].

Besler, Christian ;

Urban, Daniel ;

Watzka, Stefan ;

Lang, David ;

Rommel, Karl-Philipp ;

Kandolf, Reinhard ;

Klingel, Karin ;

Thiele, Holger ;

Linke, Axel ;

Schuler, Gerhard ;

Adams, Volker ;

Lurz, Philipp .

EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (12) :1442-1451

[7] Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy [J].

Calderon-Dominguez, Maria ;

Belmonte, Thalia ;

Quezada-Feijoo, Maribel ;

Ramos, Monica ;

Calderon-Dominguez, Juan ;

Campuzano, Oscar ;

Mangas, Alipio ;

Toro, Rocio .

SCIENTIFIC REPORTS, 2021, 11 (01)

[8] Arrhythmogenic cardiomyopathy: a disease of intercalated discs [J].

Calore, Martina ;

Lorenzon, Alessandra ;

De Bortoli, Marzia ;

Poloni, Giulia ;

Rampazzo, Alessandra .

CELL AND TISSUE RESEARCH, 2015, 360 (03) :491-500

[9]

Cammarata Giuseppe, 2018, Oncotarget, V9, P27333, DOI 10.18632/oncotarget.25542

[10] miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway [J].

Cao, Wei ;

Shi, Peng ;

Ge, Jian-Jun .

BMC CARDIOVASCULAR DISORDERS, 2017, 17

← 1 2 3 4 5 6 7 8 9 10 →